ARMPCorporate•prnewswire•
Armata Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
Sentiment:Negative (20)
Summary
(ARMP) LOS ANGELES, Sept. 4, 2025 /PRNewswire/ -- Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the treatment of...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on September 4, 2025 by prnewswire